OverviewSuggest Edit

PharmaEssentia is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases. Its lead compound is ropeginterferon alfa-2b, an interferon for myeloproliferative neoplasms and hepatitis. The company also develops treatments for gastric, gastro-esophageal, esophageal, and breast cancer, as well as psoriasis.
Employee Ratings4.8

Latest Updates

Employees (est.) (Jun 2019)190
Share Price (Jun 2021)NT$91.5
Cybersecurity ratingBMore

Key People/Management at PharmaEssentia

Kochung Lin

Kochung Lin

Founder and CEO
Albert Qin

Albert Qin

Chief Medical Officer
Craig Zimmerman

Craig Zimmerman

Vice President of US Operations
Yi-Wen Huang

Yi-Wen Huang

Senior Director, Medical Research & Clinical Operation
Chaosheng Cheng

Chaosheng Cheng

Senior Director of Biologics Manufacturing
Show more

PharmaEssentia Office Locations

PharmaEssentia has offices in Burlington and Shinjuku City
Shinjuku City, JP
2-chōme-5-12 Shinjuku
Burlington, MA, US
35 Corporate Dr #325
Show all (5)

PharmaEssentia Financials and Metrics

PharmaEssentia Revenue

Market capitalization (18-Jun-2021)


Closing stock price (18-Jun-2021)

PharmaEssentia's current market capitalization is NT$23.8 b.
Show all financial metrics

PharmaEssentia Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

PharmaEssentia Online and Social Media Presence

Embed Graph

PharmaEssentia News and Updates

Axis Therapeutics Announces Research Collaboration with PharmaEssentia for Development of TCR-T Cell Therapy in Taiwan

BUFFALO, N.Y., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Axis Therapeutics Limited, a joint venture between Athenex, Inc. (NASDAQ: ATNX) and Xiangxue Life Sciences Limited (“XLifeSc”), focused on the research, development, and commercialization of T cell immunotherapy, today announced that it has entered …

PharmaEssentia Frequently Asked Questions

  • When was PharmaEssentia founded?

    PharmaEssentia was founded in 2003.

  • Who are PharmaEssentia key executives?

    PharmaEssentia's key executives are Kochung Lin, Albert Qin and Craig Zimmerman.

  • How many employees does PharmaEssentia have?

    PharmaEssentia has 190 employees.

  • Who are PharmaEssentia competitors?

    Competitors of PharmaEssentia include Takeda Oncology, Black Diamond Therapeutics and PLIVA.

  • Where are PharmaEssentia offices?

    PharmaEssentia has offices in Burlington and Shinjuku City.

  • How many offices does PharmaEssentia have?

    PharmaEssentia has 5 offices.